Manuka Honey Sinus Rinse Study

Overview

A trial investigating the effect of a sinus rinse in people with CF

Full Title of Study: “A Pilot Study Investigating the Effects of a Manuka Honey Sinus Rinse on Sino-nasal Outcome Test Scores in Cystic Fibrosis Patients”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Basic Science
    • Masking: Single (Outcomes Assessor)
  • Study Primary Completion Date: October 31, 2021

Detailed Description

People with with CF often have bacterial infection in their air ways. There is great interest in the different types of bacteria found within these infections. This clinical trial looks at whether a novel sinus rinse device (that incorporates manuka honey) could help clear infection or reduce the amount and/or types of bacteria found within the upper airway. This study assesses the changes in the Sino-Nasal Outcome Test (SNOT-22) scores along with any changes in quality of life, before and after the use of a sinus rinse device for 30 days. In addition to this, the amount and types of bacteria found in nasal swabs, the sinus rinse solution, and sputum samples, before and after using the sinus rinse device will be investigated. Sputum samples will also be monitored for changes in composition before and after using the sinus rinse.

Interventions

  • Device: Manuka honey sinus rinse
    • Will follow a modified NHS nasal rinse protocol with the addition of manuka honey
  • Device: Standard sinus rinse
    • will follow the standard NHS nasal rinse protocol

Arms, Groups and Cohorts

  • Experimental: Experimental
    • Manuka honey sinus rinse
  • Active Comparator: Standard
    • Standard sinus rinse

Clinical Trial Outcome Measures

Primary Measures

  • Change in Sino-Nasal Outcome Test 22 (SNOT- 22) Score
    • Time Frame: Baseline and day 30 (+-7 days)
    • Does the addition of manuka honey to the sinus rinse change the Sino Nasal Outcome Test (SNOT)-22 score of patients with cystic fibrosis? The SNOT-22 scale runs from 0 -110 and a higher score indicating worse symptoms

Secondary Measures

  • Change in Cystic Fibrosis Questionnaire-Revised (CFQ-R) Score
    • Time Frame: Baseline and day 30 (+-7 days)
    • Does the addition of manuka honey to a sinus rinse change the CFQ-R score in patients with cystic fibrosis? The scale runs from 1-100 and a higher score indicates a better outcome
  • Bacterial type and number
    • Time Frame: Baseline and day 30 (+-7 days)
    • Does the addition of manuka honey to a sinus rinse impact on the bacterial type/amount found in the nasal/paranasal cavities of patients with cystic fibrosis

Participating in This Clinical Trial

Inclusion Criteria

  • The patient is willing and able to give informed consent. – The patient must be ≥ 18 years. – The patient must have an established diagnosis of CF (one or more of the following) Sweat chloride >60mEq/L Presence of two CF causing mutations. – The patient must have chronic symptoms of rhinosinusitis according to the criteria of the European Position Paper on Rhinosinusitis (appendix A). – The patient scores greater ≥ 7 on their SNOT-22 questionnaire. Exclusion Criteria:

  • The patient has ever tested positive for the bacteria Mycobacterium tuberculosis. – The patient is currently using a nasal rinse protocol. – The patient has undergone sinus surgery within 6 months. – The patient suffers from nasal bleeding. – The patient is currently undergoing systemic antibiotic therapy for infective exacerbation. – The patient is using overnight oxygen via nasal cannula. – The patient is participating in another clinical trial or has done so within the last 30 days. – The patient has a known allergy to bee products. – The patient has an objection to the use of bee products

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Swansea University
  • Collaborator
    • University Hospital of Wales
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Jamie Duckers, Principal Investigator, National Health Service, United Kingdom

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.